Cargando…

Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage

Multiple sclerosis (MS) is the autoimmune disease of the central nervous system with complex pathogenesis, different clinical courses and recurrent neurological relapses and/or progression. Despite various scientific papers that focused on early stage of MS, our study targets selective group of late...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morel, Agnieszka, Bijak, Michał, Miller, Elżbieta, Rywaniak, Joanna, Miller, Sergiusz, Saluk, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429191/ https://www.ncbi.nlm.nih.gov/pubmed/26064417 http://dx.doi.org/10.1155/2015/240918

Ejemplares similares

Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2017)

The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2016)

Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients
por: Bijak, Michal, et al.
Publicado: (2019)

Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y(12) Pathway in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
por: Pietrasik, Sylwia, et al.
Publicado: (2021)

Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Platelets miRNA as a Prediction Marker of Thrombotic Episodes
por: Bijak, Michal, et al.
Publicado: (2016)

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019)

The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis
por: Miller, Elzbieta Dorota, et al.
Publicado: (2019)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis
por: Miller, Elżbieta, et al.
Publicado: (2018)

Variation of genes encoding nitric oxide synthases and antioxidant enzymes as potential risks of multiple sclerosis development: a preliminary study
por: Wigner, Paulina, et al.
Publicado: (2022)

miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
por: Maciak, Karina, et al.
Publicado: (2021)

Flavonolignans inhibit the arachidonic acid pathway in blood platelets
por: Bijak, Michal, et al.
Publicado: (2017)

The Level of Isoprostanes as a Non-invasive Marker for in vivo Lipid Peroxidation in Secondary Progressive Multiple Sclerosis
por: Miller, Elżbieta, et al.
Publicado: (2011)

Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review
por: Maciak, Karina, et al.
Publicado: (2021)

The Role of Vitamin D in Stroke Prevention and the Effects of Its Supplementation for Post-Stroke Rehabilitation: A Narrative Review
por: Marek, Klaudia, et al.
Publicado: (2022)

The potential contribution and role of a blood platelets in autoimmune thyroid diseases
por: Tomczyńska, Małgorzata, et al.
Publicado: (2018)

Benefits from Repetitive Transcranial Magnetic Stimulation in Post-Stroke Rehabilitation
por: Starosta, Michał, et al.
Publicado: (2022)

Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets
por: Bijak, Michal, et al.
Publicado: (2018)

Nutritional Supplements and Neuroprotective Diets and Their Potential Clinical Significance in Post-Stroke Rehabilitation
por: Zielińska-Nowak, Ewa, et al.
Publicado: (2021)

Poststroke Depression as a Factor Adversely Affecting the Level of Oxidative Damage to Plasma Proteins during a Brain Stroke
por: Cichoń, Natalia, et al.
Publicado: (2015)

Biomarkers of Angiogenesis and Neuroplasticity as Promising Clinical Tools for Stroke Recovery Evaluation
por: Wlodarczyk, Lidia, et al.
Publicado: (2021)

Neuroimaging Techniques as Potential Tools for Assessment of Angiogenesis and Neuroplasticity Processes after Stroke and Their Clinical Implications for Rehabilitation and Stroke Recovery Prognosis
por: Włodarczyk, Lidia, et al.
Publicado: (2022)

Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery
por: Szelenberger, Rafał, et al.
Publicado: (2020)

Effect of Rehabilitation with Extremely Low Frequency Electromagnetic Field on Molecular Mechanism of Apoptosis in Post-Stroke Patients
por: Cichon, Natalia, et al.
Publicado: (2020)

Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders
por: Cichon, Natalia, et al.
Publicado: (2021)

Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes
por: Bijak, Michal, et al.
Publicado: (2017)

Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases
por: Miller, Elżbieta, et al.
Publicado: (2014)

Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients
por: Cichoń, Natalia, et al.
Publicado: (2018)

Benign Effect of Extremely Low-Frequency Electromagnetic Field on Brain Plasticity Assessed by Nitric Oxide Metabolism during Poststroke Rehabilitation
por: Cichoń, Natalia, et al.
Publicado: (2017)

Variation of Genes Encoding Tryptophan Catabolites Pathway Enzymes in Stroke
por: Wigner, Paulina, et al.
Publicado: (2019)

Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation
por: Cichon, Natalia, et al.
Publicado: (2021)

The Role of Supplementation with Natural Compounds in Post-Stroke Patients
por: Cichon, Natalia, et al.
Publicado: (2021)

Variations in Blood Platelet Proteome and Transcriptome Revealed Altered Expression of Transgelin-2 in Acute Coronary Syndrome Patients
por: Szelenberger, Rafał, et al.
Publicado: (2022)

Ischemic Stroke among the Symptoms Caused by the COVID-19 Infection
por: Szelenberger, Rafal, et al.
Publicado: (2020)

The Green Anti-Cancer Weapon. The Role of Natural Compounds in Bladder Cancer Treatment
por: Wigner, Paulina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e1jljch9pmi051tj10mnfr1pb0